| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Endothelial Growth Factor A | 72 | 2024 | 3493 | 5.490 |
Why?
|
| Retinal Pigment Epithelium | 14 | 2022 | 303 | 3.770 |
Why?
|
| Endothelium, Vascular | 62 | 2024 | 4420 | 3.390 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 20 | 2024 | 546 | 3.250 |
Why?
|
| Neovascularization, Physiologic | 29 | 2014 | 1347 | 2.290 |
Why?
|
| Pericytes | 9 | 2017 | 295 | 2.280 |
Why?
|
| Neovascularization, Pathologic | 40 | 2021 | 2636 | 2.110 |
Why?
|
| Endothelial Cells | 23 | 2024 | 3552 | 1.620 |
Why?
|
| Lymphangiogenesis | 8 | 2022 | 171 | 1.570 |
Why?
|
| Endothelial Growth Factors | 22 | 2003 | 672 | 1.560 |
Why?
|
| Macular Degeneration | 9 | 2022 | 1009 | 1.510 |
Why?
|
| Retina | 30 | 2021 | 2656 | 1.510 |
Why?
|
| Muscle, Smooth, Vascular | 24 | 2017 | 1488 | 1.490 |
Why?
|
| Lymphokines | 20 | 2003 | 925 | 1.480 |
Why?
|
| Retinal Neovascularization | 8 | 2017 | 288 | 1.390 |
Why?
|
| Sialoglycoproteins | 2 | 2020 | 315 | 1.190 |
Why?
|
| Capillaries | 19 | 2014 | 755 | 1.130 |
Why?
|
| Gene Expression Regulation, Developmental | 15 | 2011 | 3596 | 1.120 |
Why?
|
| Cell Communication | 17 | 2008 | 1651 | 1.090 |
Why?
|
| Sialomucins | 4 | 2024 | 18 | 1.080 |
Why?
|
| Blood Vessels | 19 | 2012 | 1111 | 1.080 |
Why?
|
| Transforming Growth Factor beta | 16 | 2011 | 1963 | 0.940 |
Why?
|
| Cattle | 48 | 2016 | 3818 | 0.940 |
Why?
|
| Cells, Cultured | 67 | 2024 | 18927 | 0.910 |
Why?
|
| Choroid | 5 | 2011 | 363 | 0.860 |
Why?
|
| Coculture Techniques | 13 | 2016 | 1334 | 0.850 |
Why?
|
| Glycocalyx | 2 | 2024 | 97 | 0.820 |
Why?
|
| Fibroblast Growth Factor 2 | 14 | 2011 | 588 | 0.800 |
Why?
|
| Animals | 172 | 2024 | 168089 | 0.800 |
Why?
|
| Diabetic Retinopathy | 7 | 2017 | 1276 | 0.800 |
Why?
|
| Signal Transduction | 34 | 2024 | 23419 | 0.790 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2022 | 127 | 0.780 |
Why?
|
| Eye | 6 | 2013 | 713 | 0.760 |
Why?
|
| Geographic Atrophy | 1 | 2022 | 91 | 0.750 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2011 | 630 | 0.740 |
Why?
|
| Pathology | 1 | 2023 | 269 | 0.710 |
Why?
|
| Microcirculation | 11 | 2014 | 1280 | 0.710 |
Why?
|
| Arteries | 6 | 2012 | 1121 | 0.690 |
Why?
|
| Retinal Vessels | 9 | 2017 | 854 | 0.690 |
Why?
|
| Cytoskeleton | 2 | 2024 | 1169 | 0.680 |
Why?
|
| Pathology, Clinical | 1 | 2023 | 376 | 0.680 |
Why?
|
| Lymphatic Vessels | 4 | 2016 | 356 | 0.650 |
Why?
|
| Cell Survival | 13 | 2016 | 5778 | 0.650 |
Why?
|
| Cell Movement | 16 | 2024 | 5195 | 0.620 |
Why?
|
| RNA, Messenger | 24 | 2017 | 12747 | 0.620 |
Why?
|
| Mice | 72 | 2024 | 81330 | 0.610 |
Why?
|
| Pigment Epithelium of Eye | 4 | 2006 | 209 | 0.610 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 563 | 0.580 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 643 | 0.580 |
Why?
|
| Blotting, Western | 19 | 2024 | 5032 | 0.580 |
Why?
|
| Angiogenesis Inhibitors | 7 | 2012 | 2047 | 0.570 |
Why?
|
| Choroidal Neovascularization | 4 | 2017 | 364 | 0.570 |
Why?
|
| Growth Substances | 15 | 2001 | 759 | 0.560 |
Why?
|
| Cell Differentiation | 26 | 2016 | 11512 | 0.560 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 698 | 0.550 |
Why?
|
| Veins | 5 | 2012 | 767 | 0.550 |
Why?
|
| Vascular Endothelial Growth Factors | 21 | 2016 | 748 | 0.540 |
Why?
|
| Fibroblast Growth Factors | 18 | 2011 | 863 | 0.540 |
Why?
|
| Receptors, Transforming Growth Factor beta | 4 | 2013 | 302 | 0.540 |
Why?
|
| Capillary Permeability | 4 | 2016 | 773 | 0.520 |
Why?
|
| Platelet-Derived Growth Factor | 8 | 2008 | 617 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 27 | 2024 | 22128 | 0.510 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 619 | 0.510 |
Why?
|
| Endothelium | 25 | 1995 | 763 | 0.500 |
Why?
|
| Vision, Ocular | 3 | 2023 | 454 | 0.490 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 13 | 2016 | 664 | 0.480 |
Why?
|
| Pregnancy, Animal | 2 | 2012 | 124 | 0.460 |
Why?
|
| Wnt Proteins | 5 | 2007 | 720 | 0.460 |
Why?
|
| Cell Proliferation | 17 | 2024 | 10423 | 0.450 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 13 | 2014 | 4567 | 0.450 |
Why?
|
| Cell Division | 32 | 2004 | 4451 | 0.450 |
Why?
|
| Inflammasomes | 2 | 2016 | 526 | 0.450 |
Why?
|
| Receptors, Notch | 4 | 2014 | 743 | 0.440 |
Why?
|
| Stress, Mechanical | 3 | 2013 | 1674 | 0.440 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2013 | 44 | 0.440 |
Why?
|
| Interleukin-1beta | 4 | 2014 | 1002 | 0.420 |
Why?
|
| Lymphatic System | 1 | 2014 | 253 | 0.420 |
Why?
|
| Membrane Proteins | 8 | 2020 | 7851 | 0.410 |
Why?
|
| Gene Expression Regulation | 9 | 2017 | 11855 | 0.410 |
Why?
|
| Stem Cells | 6 | 2010 | 3517 | 0.390 |
Why?
|
| Ciliary Body | 1 | 2012 | 168 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2014 | 4513 | 0.390 |
Why?
|
| Cholesterol | 1 | 2021 | 2902 | 0.390 |
Why?
|
| Epithelium | 4 | 2016 | 1603 | 0.380 |
Why?
|
| Blindness | 1 | 2015 | 586 | 0.360 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1852 | 0.360 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2009 | 203 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 6 | 2021 | 558 | 0.350 |
Why?
|
| Cell Line | 16 | 2019 | 15545 | 0.350 |
Why?
|
| Wnt2 Protein | 3 | 2007 | 28 | 0.340 |
Why?
|
| Inflammation | 7 | 2021 | 10759 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2020 | 4340 | 0.330 |
Why?
|
| Tamoxifen | 1 | 2014 | 965 | 0.330 |
Why?
|
| Angiogenesis Inducing Agents | 7 | 2002 | 254 | 0.330 |
Why?
|
| Prosencephalon | 1 | 2011 | 305 | 0.330 |
Why?
|
| CADASIL | 3 | 2017 | 82 | 0.320 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 235 | 0.320 |
Why?
|
| Kruppel-Like Transcription Factors | 4 | 2013 | 504 | 0.310 |
Why?
|
| rho-Associated Kinases | 1 | 2010 | 281 | 0.300 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2016 | 1651 | 0.300 |
Why?
|
| Retinal Artery | 2 | 2016 | 109 | 0.300 |
Why?
|
| Ependyma | 1 | 2008 | 56 | 0.300 |
Why?
|
| Aorta | 18 | 2006 | 2040 | 0.300 |
Why?
|
| Retinal Diseases | 1 | 2014 | 705 | 0.300 |
Why?
|
| Up-Regulation | 8 | 2016 | 4111 | 0.300 |
Why?
|
| Choroid Plexus | 2 | 2008 | 240 | 0.300 |
Why?
|
| Cell Culture Techniques | 3 | 2022 | 1662 | 0.300 |
Why?
|
| Vitreoretinopathy, Proliferative | 3 | 2017 | 76 | 0.290 |
Why?
|
| Neuropilin-1 | 3 | 2014 | 90 | 0.290 |
Why?
|
| Retinal Ganglion Cells | 2 | 2011 | 810 | 0.290 |
Why?
|
| Endocytosis | 3 | 2024 | 950 | 0.290 |
Why?
|
| Heparin | 14 | 2002 | 1632 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 9 | 2012 | 5773 | 0.290 |
Why?
|
| Wnt1 Protein | 2 | 2007 | 122 | 0.280 |
Why?
|
| Adipose Tissue, Brown | 1 | 2013 | 766 | 0.280 |
Why?
|
| Humans | 115 | 2024 | 761222 | 0.280 |
Why?
|
| Angiopoietins | 1 | 2007 | 86 | 0.280 |
Why?
|
| Trachea | 1 | 2013 | 1090 | 0.270 |
Why?
|
| Mice, Transgenic | 15 | 2017 | 9520 | 0.270 |
Why?
|
| Phenotype | 7 | 2021 | 16575 | 0.270 |
Why?
|
| Reperfusion | 1 | 2008 | 271 | 0.270 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 267 | 0.270 |
Why?
|
| Gene Expression | 11 | 2014 | 7571 | 0.270 |
Why?
|
| Protein Isoforms | 9 | 2011 | 1695 | 0.270 |
Why?
|
| Frizzled Receptors | 1 | 2006 | 91 | 0.270 |
Why?
|
| Leukocytes | 3 | 2016 | 2025 | 0.260 |
Why?
|
| Mesoderm | 4 | 2004 | 673 | 0.260 |
Why?
|
| Lens, Crystalline | 1 | 2008 | 385 | 0.260 |
Why?
|
| Receptors, Growth Factor | 5 | 2002 | 325 | 0.260 |
Why?
|
| Adipocytes | 1 | 2013 | 1190 | 0.260 |
Why?
|
| Muscle Development | 1 | 2007 | 258 | 0.260 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2007 | 275 | 0.260 |
Why?
|
| Immunohistochemistry | 14 | 2017 | 11067 | 0.260 |
Why?
|
| Culture Media, Conditioned | 6 | 2011 | 522 | 0.250 |
Why?
|
| Macrophages | 5 | 2022 | 5755 | 0.250 |
Why?
|
| Apoptosis | 10 | 2017 | 9478 | 0.240 |
Why?
|
| Hot Temperature | 1 | 2011 | 1434 | 0.240 |
Why?
|
| MicroRNAs | 1 | 2021 | 3758 | 0.240 |
Why?
|
| Vasodilation | 1 | 2009 | 966 | 0.240 |
Why?
|
| Corneal Neovascularization | 4 | 2012 | 185 | 0.240 |
Why?
|
| Neurogenesis | 1 | 2011 | 862 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2017 | 367 | 0.230 |
Why?
|
| beta Catenin | 3 | 2006 | 1042 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 420 | 0.230 |
Why?
|
| Receptors, LDL | 1 | 2006 | 489 | 0.230 |
Why?
|
| Blotting, Northern | 9 | 2014 | 1545 | 0.220 |
Why?
|
| Disease Models, Animal | 15 | 2017 | 18222 | 0.220 |
Why?
|
| Actins | 5 | 2024 | 2046 | 0.220 |
Why?
|
| Blood-Retinal Barrier | 1 | 2003 | 62 | 0.220 |
Why?
|
| Transcription, Genetic | 7 | 2007 | 7571 | 0.220 |
Why?
|
| Hemodynamics | 2 | 2013 | 4165 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 2813 | 0.220 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 7 | 2002 | 1625 | 0.220 |
Why?
|
| Mammary Glands, Animal | 1 | 2005 | 272 | 0.210 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2004 | 244 | 0.210 |
Why?
|
| Phosphorylation | 5 | 2019 | 8300 | 0.210 |
Why?
|
| Morphogenesis | 3 | 2017 | 741 | 0.210 |
Why?
|
| Embryonic Induction | 2 | 2002 | 151 | 0.210 |
Why?
|
| Eye Proteins | 3 | 2011 | 632 | 0.210 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 2 | 2012 | 8 | 0.210 |
Why?
|
| Wet Macular Degeneration | 2 | 2017 | 162 | 0.210 |
Why?
|
| Ophthalmology | 1 | 2009 | 550 | 0.200 |
Why?
|
| Aging | 5 | 2011 | 8702 | 0.200 |
Why?
|
| Macaca fascicularis | 4 | 2021 | 901 | 0.200 |
Why?
|
| Swine | 3 | 2022 | 5909 | 0.200 |
Why?
|
| Growth Inhibitors | 3 | 2007 | 374 | 0.200 |
Why?
|
| Ischemia | 6 | 2007 | 1889 | 0.190 |
Why?
|
| Endostatins | 4 | 2016 | 168 | 0.190 |
Why?
|
| Cell Death | 3 | 2016 | 1676 | 0.190 |
Why?
|
| Enzyme Activation | 4 | 2012 | 3577 | 0.190 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1026 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2012 | 3803 | 0.180 |
Why?
|
| Embryo, Mammalian | 3 | 2005 | 1668 | 0.180 |
Why?
|
| Immunoenzyme Techniques | 5 | 2010 | 1703 | 0.180 |
Why?
|
| Eicosanoids | 2 | 2013 | 282 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2004 | 616 | 0.180 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2014 | 1645 | 0.180 |
Why?
|
| Adenoviridae | 2 | 2019 | 1084 | 0.180 |
Why?
|
| Zebrafish Proteins | 3 | 2002 | 1012 | 0.180 |
Why?
|
| Wound Healing | 3 | 2007 | 2800 | 0.170 |
Why?
|
| DNA Primers | 6 | 2011 | 2814 | 0.170 |
Why?
|
| Recombinant Proteins | 9 | 2011 | 6504 | 0.170 |
Why?
|
| Financing, Organized | 1 | 2021 | 204 | 0.170 |
Why?
|
| Peripheral Nerves | 2 | 2002 | 479 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor 1 | 3 | 2011 | 193 | 0.170 |
Why?
|
| Membrane Glycoproteins | 4 | 2009 | 3696 | 0.170 |
Why?
|
| Hedgehog Proteins | 3 | 2011 | 769 | 0.160 |
Why?
|
| Homeostasis | 2 | 2009 | 3322 | 0.160 |
Why?
|
| Lysosomes | 3 | 2014 | 921 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6067 | 0.160 |
Why?
|
| Cell Adhesion | 5 | 2016 | 3091 | 0.160 |
Why?
|
| Ephrins | 2 | 2011 | 28 | 0.160 |
Why?
|
| Base Sequence | 9 | 2014 | 12404 | 0.150 |
Why?
|
| Neoplasm Metastasis | 4 | 2011 | 4909 | 0.150 |
Why?
|
| Culture Techniques | 3 | 2000 | 530 | 0.150 |
Why?
|
| Glycosylation | 2 | 2020 | 1095 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2021 | 457 | 0.150 |
Why?
|
| Corneal Transplantation | 3 | 2012 | 322 | 0.150 |
Why?
|
| Angiopoietin-1 | 3 | 2015 | 122 | 0.150 |
Why?
|
| Blood-Brain Barrier | 1 | 2004 | 1028 | 0.150 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 3412 | 0.150 |
Why?
|
| Models, Biological | 8 | 2011 | 9458 | 0.140 |
Why?
|
| History, 20th Century | 3 | 2012 | 2765 | 0.140 |
Why?
|
| Face | 1 | 2023 | 1025 | 0.140 |
Why?
|
| Epithelial Cells | 6 | 2021 | 3671 | 0.140 |
Why?
|
| Proteins | 5 | 1999 | 5993 | 0.140 |
Why?
|
| Immunoblotting | 2 | 2016 | 1644 | 0.140 |
Why?
|
| Luciferases | 2 | 2012 | 710 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 10 | 2014 | 6200 | 0.140 |
Why?
|
| Cornea | 4 | 2012 | 1327 | 0.140 |
Why?
|
| Microscopy, Electron | 3 | 2013 | 2561 | 0.140 |
Why?
|
| Amino Acid Sequence | 6 | 2020 | 13402 | 0.140 |
Why?
|
| DNA, Complementary | 4 | 2009 | 1989 | 0.140 |
Why?
|
| Lac Operon | 2 | 2008 | 237 | 0.140 |
Why?
|
| Astrocytes | 1 | 2004 | 1341 | 0.130 |
Why?
|
| Phagocytosis | 1 | 2022 | 1525 | 0.130 |
Why?
|
| Extracellular Matrix | 9 | 2007 | 1720 | 0.130 |
Why?
|
| DNA | 6 | 2017 | 7189 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 4 | 2017 | 2635 | 0.130 |
Why?
|
| Nerve Growth Factors | 5 | 2011 | 564 | 0.130 |
Why?
|
| Epoxy Compounds | 2 | 2013 | 137 | 0.130 |
Why?
|
| RNA Editing | 1 | 2017 | 149 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2008 | 696 | 0.130 |
Why?
|
| Muscle, Skeletal | 3 | 2007 | 4947 | 0.130 |
Why?
|
| Cell Lineage | 4 | 2007 | 2549 | 0.130 |
Why?
|
| Retinopathy of Prematurity | 2 | 2006 | 439 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2016 | 134 | 0.120 |
Why?
|
| Transforming Growth Factors | 3 | 1989 | 75 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2017 | 355 | 0.120 |
Why?
|
| Mice, Inbred C3H | 2 | 2008 | 914 | 0.120 |
Why?
|
| Genes, Reporter | 2 | 2012 | 1518 | 0.120 |
Why?
|
| Receptor, TIE-2 | 3 | 2013 | 176 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2008 | 3788 | 0.120 |
Why?
|
| Flavanones | 1 | 1994 | 74 | 0.110 |
Why?
|
| Receptor, erbB-2 | 1 | 2005 | 2553 | 0.110 |
Why?
|
| Organ Specificity | 4 | 2010 | 1963 | 0.110 |
Why?
|
| Graves Ophthalmopathy | 1 | 2016 | 133 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2012 | 1567 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 433 | 0.110 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 150 | 0.110 |
Why?
|
| Models, Animal | 2 | 2014 | 2114 | 0.110 |
Why?
|
| Rats | 15 | 2011 | 23705 | 0.110 |
Why?
|
| Cell Count | 6 | 2017 | 1831 | 0.110 |
Why?
|
| Cardiovascular System | 1 | 2001 | 836 | 0.110 |
Why?
|
| Ornithine Decarboxylase | 4 | 1992 | 63 | 0.110 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1996 | 537 | 0.110 |
Why?
|
| Animals, Newborn | 3 | 2011 | 2665 | 0.110 |
Why?
|
| Heart | 3 | 2022 | 4431 | 0.100 |
Why?
|
| Liver Regeneration | 1 | 2014 | 214 | 0.100 |
Why?
|
| Arachidonic Acid | 1 | 1994 | 427 | 0.100 |
Why?
|
| Thrombospondin 1 | 2 | 2011 | 257 | 0.100 |
Why?
|
| Oligodendroglia | 1 | 1996 | 537 | 0.100 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2012 | 49 | 0.100 |
Why?
|
| Antigens, Differentiation | 3 | 2007 | 918 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2227 | 0.100 |
Why?
|
| Eye Diseases | 2 | 2017 | 653 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 790 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 8531 | 0.100 |
Why?
|
| Mice, Knockout | 7 | 2017 | 14392 | 0.100 |
Why?
|
| Tropoelastin | 1 | 2011 | 28 | 0.100 |
Why?
|
| Rabbits | 7 | 2017 | 4750 | 0.100 |
Why?
|
| Bruch Membrane | 1 | 2011 | 65 | 0.100 |
Why?
|
| Lasers, Semiconductor | 1 | 2011 | 41 | 0.100 |
Why?
|
| Muscles | 2 | 1994 | 1568 | 0.100 |
Why?
|
| Antibodies | 2 | 2017 | 2415 | 0.100 |
Why?
|
| Elastic Tissue | 1 | 2011 | 66 | 0.100 |
Why?
|
| Muscular Dystrophies | 1 | 1994 | 391 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 1168 | 0.090 |
Why?
|
| Vitreous Body | 7 | 2017 | 399 | 0.090 |
Why?
|
| Quinoxalines | 1 | 2013 | 296 | 0.090 |
Why?
|
| Neuropilins | 1 | 2011 | 12 | 0.090 |
Why?
|
| Epidermis | 1 | 2014 | 526 | 0.090 |
Why?
|
| Caspases | 1 | 2014 | 878 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2012 | 2974 | 0.090 |
Why?
|
| Caspase 3 | 1 | 2013 | 730 | 0.090 |
Why?
|
| Neoplasms | 9 | 2014 | 22142 | 0.090 |
Why?
|
| Smad Proteins | 1 | 2011 | 156 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 206 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 596 | 0.090 |
Why?
|
| Pregnancy | 6 | 2012 | 29893 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 2414 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1463 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 1762 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 119 | 0.090 |
Why?
|
| Membrane Transport Proteins | 4 | 2012 | 1031 | 0.090 |
Why?
|
| Semaphorins | 1 | 2011 | 96 | 0.090 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2011 | 100 | 0.090 |
Why?
|
| Iris | 3 | 1996 | 231 | 0.090 |
Why?
|
| Binding Sites | 3 | 2012 | 5988 | 0.090 |
Why?
|
| Intracellular Space | 1 | 2011 | 197 | 0.090 |
Why?
|
| Blood-Aqueous Barrier | 1 | 2009 | 7 | 0.090 |
Why?
|
| Retinal Degeneration | 1 | 2014 | 414 | 0.090 |
Why?
|
| Fibroblasts | 6 | 2005 | 4138 | 0.090 |
Why?
|
| Neurites | 2 | 2011 | 391 | 0.090 |
Why?
|
| Serpins | 1 | 2011 | 247 | 0.090 |
Why?
|
| Microvessels | 1 | 2014 | 580 | 0.090 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 258 | 0.080 |
Why?
|
| Hyaluronic Acid | 2 | 1991 | 484 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 1900 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 2455 | 0.080 |
Why?
|
| Adrenal Cortex | 4 | 1993 | 134 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 316 | 0.080 |
Why?
|
| Alternative Splicing | 5 | 2002 | 1087 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 4021 | 0.080 |
Why?
|
| Skin Neoplasms | 3 | 2016 | 5809 | 0.080 |
Why?
|
| Collagen | 6 | 2002 | 2635 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 1992 | 593 | 0.080 |
Why?
|
| Glycoproteins | 5 | 2012 | 2203 | 0.080 |
Why?
|
| Tissue Scaffolds | 1 | 2016 | 932 | 0.080 |
Why?
|
| Mesenteric Veins | 1 | 2009 | 86 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2008 | 43 | 0.080 |
Why?
|
| Molecular Sequence Data | 7 | 2014 | 17598 | 0.080 |
Why?
|
| Male | 30 | 2021 | 360703 | 0.080 |
Why?
|
| Plant Lectins | 1 | 1988 | 103 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2008 | 69 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2012 | 638 | 0.080 |
Why?
|
| Mutation | 3 | 2021 | 30004 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2009 | 260 | 0.080 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 1967 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2011 | 748 | 0.080 |
Why?
|
| Retinal Neurons | 1 | 2008 | 67 | 0.080 |
Why?
|
| Trans-Activators | 3 | 2003 | 2846 | 0.070 |
Why?
|
| Carboxy-Lyases | 2 | 1978 | 85 | 0.070 |
Why?
|
| Gene Targeting | 3 | 2017 | 838 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 613 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2008 | 169 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 425 | 0.070 |
Why?
|
| Solubility | 1 | 2009 | 1085 | 0.070 |
Why?
|
| Epidermal Growth Factor | 3 | 2005 | 699 | 0.070 |
Why?
|
| Aquaporins | 1 | 2008 | 174 | 0.070 |
Why?
|
| Angiogenic Proteins | 1 | 2008 | 101 | 0.070 |
Why?
|
| Axons | 4 | 1990 | 1671 | 0.070 |
Why?
|
| Cell Separation | 3 | 2015 | 1721 | 0.070 |
Why?
|
| Cyclohexanes | 1 | 2008 | 151 | 0.070 |
Why?
|
| Electroretinography | 1 | 2009 | 524 | 0.070 |
Why?
|
| Myocardium | 3 | 1999 | 4746 | 0.070 |
Why?
|
| Amides | 1 | 2010 | 449 | 0.070 |
Why?
|
| MyoD Protein | 1 | 2007 | 141 | 0.070 |
Why?
|
| Imidazoles | 1 | 2013 | 1172 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 1992 | 805 | 0.070 |
Why?
|
| Teratoma | 2 | 1992 | 404 | 0.070 |
Why?
|
| Cilia | 1 | 2011 | 495 | 0.070 |
Why?
|
| E-Selectin | 1 | 2009 | 577 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2016 | 2567 | 0.070 |
Why?
|
| Collateral Circulation | 2 | 1987 | 293 | 0.070 |
Why?
|
| Sesquiterpenes | 1 | 2008 | 176 | 0.070 |
Why?
|
| Intestines | 1 | 2016 | 1908 | 0.070 |
Why?
|
| P-Selectin | 1 | 2009 | 599 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 691 | 0.070 |
Why?
|
| Glycosaminoglycans | 2 | 1988 | 607 | 0.070 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 1225 | 0.070 |
Why?
|
| RNA | 1 | 2016 | 2709 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2006 | 138 | 0.070 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 2802 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2007 | 10756 | 0.070 |
Why?
|
| Leydig Cells | 1 | 2006 | 55 | 0.070 |
Why?
|
| Angiopoietin-2 | 1 | 2007 | 173 | 0.070 |
Why?
|
| Allergy and Immunology | 1 | 2008 | 177 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2008 | 323 | 0.070 |
Why?
|
| Body Patterning | 2 | 2002 | 633 | 0.060 |
Why?
|
| Point Mutation | 2 | 2004 | 1593 | 0.060 |
Why?
|
| Venules | 2 | 2002 | 161 | 0.060 |
Why?
|
| Nerve Regeneration | 2 | 1989 | 796 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2854 | 0.060 |
Why?
|
| Tissue Extracts | 3 | 1984 | 139 | 0.060 |
Why?
|
| Ligands | 2 | 2006 | 3264 | 0.060 |
Why?
|
| Nitric Oxide | 2 | 2013 | 2137 | 0.060 |
Why?
|
| Female | 26 | 2017 | 392552 | 0.060 |
Why?
|
| Fibronectins | 3 | 2004 | 724 | 0.060 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1597 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 1334 | 0.060 |
Why?
|
| Arterioles | 2 | 2002 | 250 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 195 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 1996 | 775 | 0.060 |
Why?
|
| Tumor Escape | 1 | 2008 | 371 | 0.060 |
Why?
|
| Tissue Array Analysis | 1 | 2006 | 550 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 574 | 0.060 |
Why?
|
| Fucose | 1 | 2005 | 122 | 0.060 |
Why?
|
| Retinal Vein Occlusion | 2 | 1996 | 149 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2017 | 12159 | 0.060 |
Why?
|
| Atrophy | 1 | 2009 | 1633 | 0.060 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2004 | 43 | 0.060 |
Why?
|
| Salivary Glands | 1 | 2006 | 229 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1505 | 0.060 |
Why?
|
| Mitogens | 1 | 1984 | 229 | 0.060 |
Why?
|
| Caveolins | 1 | 2004 | 102 | 0.060 |
Why?
|
| Phenyl Ethers | 1 | 2004 | 62 | 0.060 |
Why?
|
| Fibrosarcoma | 2 | 2005 | 308 | 0.060 |
Why?
|
| Neuregulin-1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2004 | 144 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1480 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2014 | 1053 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1994 | 2820 | 0.060 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2005 | 166 | 0.060 |
Why?
|
| Receptor, erbB-3 | 1 | 2005 | 142 | 0.060 |
Why?
|
| Erythropoiesis | 1 | 2008 | 683 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 3778 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 1988 | 1607 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 902 | 0.060 |
Why?
|
| Smad3 Protein | 1 | 2003 | 166 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2008 | 254 | 0.050 |
Why?
|
| Basement Membrane | 3 | 1990 | 348 | 0.050 |
Why?
|
| Cytosol | 1 | 2006 | 883 | 0.050 |
Why?
|
| Models, Cardiovascular | 2 | 2001 | 983 | 0.050 |
Why?
|
| Plasmids | 2 | 2008 | 2261 | 0.050 |
Why?
|
| Liver | 3 | 2014 | 7512 | 0.050 |
Why?
|
| Transfection | 3 | 2008 | 5748 | 0.050 |
Why?
|
| Thrombin | 5 | 1995 | 593 | 0.050 |
Why?
|
| Gels | 1 | 2004 | 420 | 0.050 |
Why?
|
| Clathrin | 1 | 2024 | 256 | 0.050 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2002 | 16 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2004 | 255 | 0.050 |
Why?
|
| Graft Survival | 2 | 2012 | 3843 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2015 | 550 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2004 | 270 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 351 | 0.050 |
Why?
|
| Integrins | 2 | 1997 | 835 | 0.050 |
Why?
|
| Embryo, Nonmammalian | 2 | 1998 | 904 | 0.050 |
Why?
|
| Thalidomide | 1 | 2008 | 885 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 4167 | 0.050 |
Why?
|
| Connexins | 1 | 2004 | 352 | 0.050 |
Why?
|
| Mitochondria | 2 | 2013 | 3620 | 0.050 |
Why?
|
| COS Cells | 2 | 2005 | 1129 | 0.050 |
Why?
|
| Retinal Pigments | 1 | 2021 | 83 | 0.050 |
Why?
|
| Tight Junctions | 1 | 2004 | 324 | 0.050 |
Why?
|
| Podocytes | 1 | 2006 | 398 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1132 | 0.050 |
Why?
|
| Dependovirus | 2 | 2017 | 712 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 651 | 0.050 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2004 | 339 | 0.050 |
Why?
|
| Culture Media | 3 | 1989 | 894 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2010 | 2468 | 0.050 |
Why?
|
| Adult | 11 | 2022 | 221120 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 3726 | 0.050 |
Why?
|
| Endothelium, Lymphatic | 2 | 2012 | 63 | 0.050 |
Why?
|
| Oxygen | 2 | 2017 | 4228 | 0.050 |
Why?
|
| Protein Binding | 3 | 2012 | 9297 | 0.050 |
Why?
|
| Glucose | 2 | 2017 | 4342 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2017 | 15920 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 1935 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2002 | 276 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1246 | 0.040 |
Why?
|
| Histamine | 3 | 1988 | 499 | 0.040 |
Why?
|
| Calcium | 3 | 1978 | 5719 | 0.040 |
Why?
|
| Hypothalamus | 2 | 1986 | 999 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2004 | 756 | 0.040 |
Why?
|
| Molecular Weight | 4 | 1989 | 2171 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2014 | 3606 | 0.040 |
Why?
|
| Serotonin | 4 | 1988 | 1042 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4935 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3777 | 0.040 |
Why?
|
| Lectins | 2 | 1994 | 489 | 0.040 |
Why?
|
| Osmotic Pressure | 1 | 1999 | 137 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 237 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 2692 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2001 | 725 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2012 | 4481 | 0.040 |
Why?
|
| Gestational Age | 2 | 2006 | 3580 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2006 | 2881 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2006 | 1230 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2004 | 719 | 0.040 |
Why?
|
| Permeability | 1 | 2001 | 721 | 0.040 |
Why?
|
| Skin | 2 | 2016 | 4473 | 0.040 |
Why?
|
| Ribonucleases | 1 | 1999 | 264 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 9567 | 0.040 |
Why?
|
| Saphenous Vein | 2 | 1996 | 516 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4404 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2005 | 656 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2803 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2872 | 0.040 |
Why?
|
| Tretinoin | 2 | 1992 | 517 | 0.040 |
Why?
|
| Heparitin Sulfate | 2 | 1989 | 223 | 0.040 |
Why?
|
| Disease Progression | 1 | 2015 | 13511 | 0.040 |
Why?
|
| Phenols | 1 | 2021 | 517 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 4 | 2008 | 9187 | 0.040 |
Why?
|
| Prostate | 1 | 2006 | 1772 | 0.040 |
Why?
|
| Heterozygote | 1 | 2004 | 2778 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2008 | 2981 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 1737 | 0.030 |
Why?
|
| Aged | 7 | 2022 | 169292 | 0.030 |
Why?
|
| Blood Platelets | 2 | 1978 | 2477 | 0.030 |
Why?
|
| Alleles | 1 | 2008 | 6857 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2004 | 1423 | 0.030 |
Why?
|
| Genotype | 1 | 2011 | 12985 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2006 | 1233 | 0.030 |
Why?
|
| RNA Interference | 1 | 2005 | 2816 | 0.030 |
Why?
|
| Liver Neoplasms | 3 | 2010 | 4310 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 2915 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 206 | 0.030 |
Why?
|
| Cell Line, Tumor | 5 | 2014 | 16954 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2017 | 221 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1996 | 197 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 1751 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 1998 | 433 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2008 | 2320 | 0.030 |
Why?
|
| Neurons | 3 | 2007 | 9429 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1977 | 346 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1702 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 385 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2006 | 4009 | 0.030 |
Why?
|
| Drug Synergism | 3 | 1989 | 1756 | 0.030 |
Why?
|
| Chemokines, CC | 1 | 1996 | 283 | 0.030 |
Why?
|
| United States | 1 | 2023 | 72341 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1998 | 2740 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1990 | 3661 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 3 | 1986 | 951 | 0.030 |
Why?
|
| Venous Insufficiency | 1 | 1996 | 108 | 0.030 |
Why?
|
| Gap Junctions | 1 | 1997 | 230 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1866 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2002 | 1273 | 0.030 |
Why?
|
| Drug Stability | 1 | 1995 | 288 | 0.030 |
Why?
|
| Cyclic AMP | 2 | 1990 | 1462 | 0.030 |
Why?
|
| Epiretinal Membrane | 1 | 2015 | 73 | 0.030 |
Why?
|
| Immunoassay | 2 | 1989 | 743 | 0.030 |
Why?
|
| Quinacrine | 1 | 1994 | 24 | 0.030 |
Why?
|
| Keratin-1 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 1988 | 1059 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 1997 | 366 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 1998 | 962 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 379 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 2017 | 292 | 0.030 |
Why?
|
| Peptides | 2 | 1986 | 4353 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1995 | 278 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1994 | 93 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1994 | 197 | 0.030 |
Why?
|
| Phospholipase D | 1 | 1994 | 67 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1996 | 1140 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 1993 | 37 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 330 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 1992 | 6125 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5871 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 1993 | 47 | 0.030 |
Why?
|
| Mitomycin | 1 | 1994 | 263 | 0.030 |
Why?
|
| Thymidine | 2 | 1986 | 296 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1994 | 204 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1994 | 235 | 0.030 |
Why?
|
| Pheochromocytoma | 4 | 1990 | 328 | 0.030 |
Why?
|
| Staining and Labeling | 4 | 1995 | 1080 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 1993 | 53 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1996 | 1150 | 0.030 |
Why?
|
| Kinetics | 4 | 1996 | 6312 | 0.030 |
Why?
|
| Thrombospondins | 1 | 1994 | 195 | 0.030 |
Why?
|
| Introns | 1 | 1996 | 968 | 0.030 |
Why?
|
| Retinal Detachment | 2 | 2016 | 429 | 0.030 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1994 | 257 | 0.030 |
Why?
|
| Laminin | 3 | 1991 | 407 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 1498 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 3446 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3245 | 0.030 |
Why?
|
| Epoxide Hydrolases | 1 | 2013 | 122 | 0.030 |
Why?
|
| Optic Nerve Injuries | 1 | 1994 | 150 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 909 | 0.030 |
Why?
|
| Optic Disk Drusen | 1 | 2013 | 38 | 0.030 |
Why?
|
| Propranolol | 1 | 1994 | 490 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 864 | 0.030 |
Why?
|
| Prostaglandins | 1 | 1993 | 398 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1994 | 361 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2007 | 3482 | 0.030 |
Why?
|
| Mitomycins | 1 | 1992 | 46 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1994 | 557 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1128 | 0.020 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 20982 | 0.020 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 2381 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2013 | 226 | 0.020 |
Why?
|
| Fluorescein Angiography | 2 | 1996 | 1062 | 0.020 |
Why?
|
| Dextrans | 1 | 1994 | 574 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1602 | 0.020 |
Why?
|
| Plasminogen | 1 | 1991 | 143 | 0.020 |
Why?
|
| Leg | 1 | 1996 | 1087 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2568 | 0.020 |
Why?
|
| Chemotaxis | 3 | 1984 | 598 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 1994 | 260 | 0.020 |
Why?
|
| Glutaral | 1 | 1991 | 76 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1992 | 370 | 0.020 |
Why?
|
| Flavonoids | 1 | 1994 | 444 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1022 | 0.020 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 1991 | 136 | 0.020 |
Why?
|
| Polyvinyls | 1 | 1991 | 154 | 0.020 |
Why?
|
| Extraembryonic Membranes | 2 | 1981 | 38 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 244 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 1992 | 366 | 0.020 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 791 | 0.020 |
Why?
|
| Chromatography | 1 | 1990 | 188 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2014 | 790 | 0.020 |
Why?
|
| Exons | 1 | 1996 | 2380 | 0.020 |
Why?
|
| Neuropilin-2 | 1 | 2009 | 55 | 0.020 |
Why?
|
| Lung | 2 | 2013 | 9979 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1984 | 5921 | 0.020 |
Why?
|
| Embryonal Carcinoma Stem Cells | 1 | 1989 | 20 | 0.020 |
Why?
|
| Nitrous Acid | 1 | 1989 | 8 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 242 | 0.020 |
Why?
|
| Visual Pathways | 1 | 1994 | 550 | 0.020 |
Why?
|
| Bucladesine | 1 | 1989 | 118 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 982 | 0.020 |
Why?
|
| Fluorouracil | 1 | 1994 | 1642 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 413 | 0.020 |
Why?
|
| Isoelectric Point | 2 | 1986 | 76 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5103 | 0.020 |
Why?
|
| Endotoxins | 1 | 1991 | 520 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1988 | 56 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 238 | 0.020 |
Why?
|
| Tritium | 2 | 1986 | 706 | 0.020 |
Why?
|
| CHO Cells | 2 | 2005 | 1379 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2091 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 1999 | 2133 | 0.020 |
Why?
|
| Tissue Distribution | 3 | 1994 | 2263 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 296 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 542 | 0.020 |
Why?
|
| Hemangiosarcoma | 1 | 2010 | 215 | 0.020 |
Why?
|
| Lanthanum | 2 | 1978 | 30 | 0.020 |
Why?
|
| Limbus Corneae | 1 | 2009 | 144 | 0.020 |
Why?
|
| Factor Xa | 1 | 1989 | 166 | 0.020 |
Why?
|
| Oncogenes | 1 | 1994 | 1220 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1991 | 961 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1989 | 175 | 0.020 |
Why?
|
| Vitamin A | 1 | 1991 | 612 | 0.020 |
Why?
|
| Cricetinae | 2 | 2005 | 2412 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2008 | 125 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1994 | 1603 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1990 | 1376 | 0.020 |
Why?
|
| Chromium Radioisotopes | 1 | 1987 | 34 | 0.020 |
Why?
|
| Rhodamine 123 | 1 | 1987 | 37 | 0.020 |
Why?
|
| Acridine Orange | 1 | 1987 | 28 | 0.020 |
Why?
|
| Isoproterenol | 2 | 1978 | 396 | 0.020 |
Why?
|
| Forecasting | 1 | 1996 | 2928 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1994 | 808 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2011 | 731 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 2193 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 581 | 0.020 |
Why?
|
| Hybridomas | 1 | 1988 | 443 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1988 | 328 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1989 | 406 | 0.020 |
Why?
|
| Chick Embryo | 4 | 1981 | 977 | 0.020 |
Why?
|
| Fibrosis | 1 | 1994 | 2052 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 1989 | 3057 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1749 | 0.020 |
Why?
|
| Rhodamines | 1 | 1987 | 177 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1988 | 819 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1987 | 387 | 0.020 |
Why?
|
| Cortisone | 1 | 1986 | 87 | 0.020 |
Why?
|
| Protamines | 1 | 1986 | 112 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1990 | 1202 | 0.020 |
Why?
|
| Time Factors | 3 | 2004 | 39957 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2005 | 74 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1984 | 306 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1978 | 897 | 0.020 |
Why?
|
| Middle Aged | 8 | 2017 | 220858 | 0.010 |
Why?
|
| Kidney | 2 | 2013 | 7033 | 0.010 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 382 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2011 | 1495 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2016 | 3313 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2475 | 0.010 |
Why?
|
| Epinephrine | 2 | 1978 | 791 | 0.010 |
Why?
|
| Hormones | 1 | 1988 | 868 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1986 | 559 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 2199 | 0.010 |
Why?
|
| Autoantigens | 1 | 2008 | 888 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4243 | 0.010 |
Why?
|
| Dimerization | 1 | 2005 | 887 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 1986 | 617 | 0.010 |
Why?
|
| Myosins | 1 | 1984 | 404 | 0.010 |
Why?
|
| Neutrophils | 1 | 2016 | 3763 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 705 | 0.010 |
Why?
|
| Proteomics | 1 | 2016 | 3840 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3417 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 2504 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1987 | 1200 | 0.010 |
Why?
|
| Cartilage | 1 | 1986 | 807 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 564 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 2010 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 7386 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 620 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2864 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 1989 | 1348 | 0.010 |
Why?
|
| Zebrafish | 1 | 2012 | 3000 | 0.010 |
Why?
|
| Hippocampus | 1 | 1993 | 3754 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1996 | 6567 | 0.010 |
Why?
|
| Seizures | 1 | 1993 | 2965 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2005 | 2621 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2006 | 26200 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2916 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 8164 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1983 | 625 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 3 | 1990 | 732 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1991 | 4201 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 812 | 0.010 |
Why?
|
| Bone Development | 1 | 2002 | 472 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 2527 | 0.010 |
Why?
|
| Ectoderm | 1 | 1998 | 137 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2002 | 683 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 22174 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1999 | 318 | 0.010 |
Why?
|
| Imipramine | 1 | 1978 | 98 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2002 | 711 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 321 | 0.010 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 2087 | 0.010 |
Why?
|
| Skull | 1 | 2002 | 818 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1978 | 452 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1989 | 4537 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1977 | 323 | 0.010 |
Why?
|
| Chemokine CCL1 | 1 | 1996 | 20 | 0.010 |
Why?
|
| Fetus | 1 | 1984 | 1864 | 0.010 |
Why?
|
| Placenta | 1 | 2006 | 1711 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 1978 | 422 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2002 | 1144 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 792 | 0.010 |
Why?
|
| NADPH Dehydrogenase | 1 | 1995 | 44 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 257 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1994 | 20118 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 3163 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 58952 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 1996 | 223 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1100 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1998 | 2175 | 0.010 |
Why?
|
| Nerve Crush | 1 | 1994 | 77 | 0.010 |
Why?
|
| DNA Replication | 1 | 1981 | 1415 | 0.010 |
Why?
|
| Monocytes | 1 | 2003 | 2570 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2010 | 4251 | 0.010 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1993 | 37 | 0.010 |
Why?
|
| RNA Probes | 1 | 1993 | 111 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1993 | 203 | 0.010 |
Why?
|
| Biological Transport | 1 | 1978 | 2081 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1993 | 158 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1984 | 3111 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1083 | 0.010 |
Why?
|
| Chondrosarcoma | 2 | 1986 | 295 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1992 | 317 | 0.010 |
Why?
|
| Endoderm | 1 | 1992 | 160 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1996 | 914 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 2003 | 10203 | 0.010 |
Why?
|
| Random Allocation | 1 | 1996 | 2393 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 42225 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1991 | 166 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1986 | 1535 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1728 | 0.010 |
Why?
|
| Fertilization in Vitro | 1 | 1998 | 1292 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 5783 | 0.010 |
Why?
|
| Chorion | 2 | 1980 | 112 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1990 | 201 | 0.010 |
Why?
|
| Aprotinin | 1 | 1989 | 94 | 0.000 |
Why?
|
| Phosphates | 1 | 1992 | 763 | 0.000 |
Why?
|
| Half-Life | 1 | 1989 | 649 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80675 | 0.000 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1986 | 58 | 0.000 |
Why?
|
| Brain | 1 | 1994 | 27094 | 0.000 |
Why?
|
| Reference Values | 1 | 1994 | 4921 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1989 | 1262 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 13386 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1989 | 616 | 0.000 |
Why?
|
| Child | 1 | 1994 | 80154 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12101 | 0.000 |
Why?
|
| Sciatic Nerve | 1 | 1989 | 618 | 0.000 |
Why?
|
| Adolescent | 1 | 1994 | 88300 | 0.000 |
Why?
|
| Chromatography, Affinity | 1 | 1986 | 525 | 0.000 |
Why?
|
| Pulmonary Circulation | 1 | 1987 | 737 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59222 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1984 | 112 | 0.000 |
Why?
|
| Chickens | 1 | 1986 | 857 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1983 | 294 | 0.000 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 1989 | 951 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 1607 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1983 | 641 | 0.000 |
Why?
|
| Polyethylene Terephthalates | 1 | 1983 | 112 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1986 | 959 | 0.000 |
Why?
|
| Action Potentials | 1 | 1989 | 1830 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1983 | 944 | 0.000 |
Why?
|
| Allantois | 1 | 1980 | 32 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1993 | 8642 | 0.000 |
Why?
|
| Aqueous Humor | 1 | 1980 | 153 | 0.000 |
Why?
|
| Lenses, Intraocular | 1 | 1981 | 139 | 0.000 |
Why?
|
| Amino Acids | 1 | 1986 | 1703 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1993 | 12341 | 0.000 |
Why?
|
| Milk, Human | 1 | 1983 | 486 | 0.000 |
Why?
|
| Cats | 1 | 1980 | 974 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 1990 | 3571 | 0.000 |
Why?
|
| Dogs | 1 | 1983 | 3832 | 0.000 |
Why?
|
| Muscle, Smooth | 1 | 1980 | 927 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1986 | 3594 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1986 | 2293 | 0.000 |
Why?
|
| Melanoma | 1 | 1986 | 5694 | 0.000 |
Why?
|